- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in BioNTech
BioNTech Begins Trials Of mRNA-based Malaria Vaccine
Scientists around the world have been working for decades to develop a vaccine to prevent malaria, which infects millions of people every year and leads to hundreds of thousands of deaths - most of them babies and young children in the poorest parts of Africa
Read MoreGermany Sends First Batch Of BioNTech Vaccines To Covid Hit China
The shipment comes after China agreed to allow German nationals in China to get the shot following a deal during Chancellor Olaf Scholz's visit in Beijing last month, with the German leader pressing for Beijing to allow the shot to be made freely available to Chinese citizens as well
Read MorePfizer, BioNTech Omicron Booster Delivers Strong Response
Omicron-tailored shots made by Pfizer and rival Moderna Inc have already been given the green light in the United States for adults as well as for children as young as five years
Read MorePfizer, BioNTech Seek FDA Approval For New Covid Boosters For Kids
The application comes just days after Moderna also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11
Read MoreModerna Sues Pfizer & BioNTech For Patent Infringement Over mRNA Vaccine
Moderna believes that Pfizer and BioNTech's COVID-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology. This groundbreaking technology was critical to the development of Moderna's own mRNA COVID-19 vaccine, Spikevax
Read MorePfizer Says COVID-19 Vaccine Works In Kids Ages 5 To 11
But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.
Read MoreSerum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU
The letter also mentions that AstraZeneca-SII Covishield has been manufactured under technology transfer from Oxford/AstraZeneca and that clinical trials of the vaccine have been conducted successfully abroad and has been approved by MHRA for emergency use approval.
Read MoreFDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs Up Expected
J&J's vaccine uses a common cold virus known as adenovirus type 26 to introduce coronavirus proteins into cells in the body and trigger an immune response.
Read MorePfizer, BioNTech begin testing of third dose against new COVID-19 variants
Pfizer, BioNTech begin testing of third dose against new COVID-19 variants
Read MoreBioNTech to produce 2 billion doses of COVID-19 vaccine in 2021 amid surge in global demand
BioNTech to produce 2 billion doses of COVID-19 vaccine in 2021 amid surge in global demand
Read MoreJ&J Vaccine Adds To COVID-19 Armoury, Includes South African Variant
J&J shares were down 4% at $162.7 at 1700 GMT, with some Wall Street analysts saying its vaccine's effectiveness was below those of rivals. Moderna's stock gained 8% to $172.80.
Read MoreNew Zealand's COVID-19 vaccine slated for possible approval next week
New Zealand's COVID-19 vaccine slated for possible approval next week
Read MorePfizer, BioNTech to scale-up vaccine production amid reports on shortage in deliveries
Pfizer, BioNTech to scale-up vaccine production amid reports on shortage in deliveries
Read MoreBiden receives second dose of Pfizer-BioNTech coronavirus vaccine
Biden receives second dose of Pfizer-BioNTech coronavirus vaccine
Read MoreEU secures deal to double Pfizer-BioNTech vaccine supply
EU secures deal to double Pfizer-BioNTech vaccine supply
Read More